Ireland
--:--IST
Starting soon Not applicable

Management of Intractable Trigeminal Neuralgia of Multiple Sclerosis Patients <Bassiouni Technique>

NCT07811973 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2026-11-29
Last updated
2026-11-18

Condition(s) studied

Trigeminal Neuralgia

Investigational drug(s) / intervention(s)

Arachnoid nerve detethering

Arachnoid nerve detethering: Endoscopic assisted

Study summary

This study aims to evaluate the clinical significance of arachnoid-trigeminal nerve conflict in patients with medically refractory trigeminal neuralgia without demonstrable neurovascular conflict on preoperative magnetic resonance imaging (MRI). Patients undergoing surgical exploration will be assessed clinically, radiologically, and intraoperatively for the presence and characteristics of arachnoid adhesions or tethering involving the trigeminal nerve. Endoscopic-assisted arachnoid release will be performed when appropriate. Postoperative pain outcome will be evaluated using the Barrow Neurological Institute (BNI) pain intensity score and the Visual Analog Scale (VAS). Recurrence, postoperative complications, MRI-intraoperative correlation, and potential predictors of favorable surgical outcome will also be evaluated.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age more 18 * Failed medical treatment Exclusion Criteria: * Vascular compression * Tumors

Primary outcome measure(s)

  • Bni (Barrow Neurological Institute) score improvement — 2years
    Pain free without medication

Trial sites (1)

FacilityCityRegionStatus
Klinikum St Marien Amberg Amberg Germany
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07811973 on ClinicalTrials.gov ↗ ← All trials in Germany